Tags

Type your tag names separated by a space and hit enter

Chronic kidney disease, dyslipidemia, and atherosclerosis.
J Atheroscler Thromb. 2012; 19(4):299-315.JA

Abstract

Patients with chronic kidney disease (CKD) are at an increased risk not only for end-stage kidney disease (ESKD) but also for cardiovascular disease (CVD). In this review article, we summarize the current evidence of CKD as a high-risk condition for CVD based on reports from Japan and other countries to draw attention to the close clinical association between CKD and CVD. Several epidemiologic studies have shown that the presence of CKD and reduced renal function are independent predictors of CVD also in Japan. According to a post-hoc analysis of CASE-J, the power of CKD as a predictor of CVD is as strong as diabetes mellitus and a previous history of ischemic heart disease. CKD worsens classical risk factors including hypertension and dyslipidemia, and dyslipidemia is associated with increased thickness and stiffness of large arteries independent of major confounders. A post-hoc analysis of MEGA indicates that lipid-lowering therapy with statins reduces the risk of CVD, and that it appears to be more efficacious in patients with than without CKD. These reports from Japan and other countries suggest that CKD should be regarded as a high-risk condition comparable to diabetes mellitus, and that strict control of dyslipidemia would be beneficial in preventing CVD, at least early stages of CKD.

Authors+Show Affiliations

Department of Geriatrics and Vascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Osaka, Japan. t-shoji@med.osaka-cu.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22166970

Citation

Shoji, Tetsuo, et al. "Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis." Journal of Atherosclerosis and Thrombosis, vol. 19, no. 4, 2012, pp. 299-315.
Shoji T, Abe T, Matsuo H, et al. Chronic kidney disease, dyslipidemia, and atherosclerosis. J Atheroscler Thromb. 2012;19(4):299-315.
Shoji, T., Abe, T., Matsuo, H., Egusa, G., Yamasaki, Y., Kashihara, N., Shirai, K., & Kashiwagi, A. (2012). Chronic kidney disease, dyslipidemia, and atherosclerosis. Journal of Atherosclerosis and Thrombosis, 19(4), 299-315.
Shoji T, et al. Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis. J Atheroscler Thromb. 2012;19(4):299-315. PubMed PMID: 22166970.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chronic kidney disease, dyslipidemia, and atherosclerosis. AU - Shoji,Tetsuo, AU - Abe,Takaaki, AU - Matsuo,Hiroshi, AU - Egusa,Genshi, AU - Yamasaki,Yoshimitsu, AU - Kashihara,Naoki, AU - Shirai,Kohji, AU - Kashiwagi,Atsunori, AU - ,, Y1 - 2011/12/14/ PY - 2011/12/15/entrez PY - 2011/12/15/pubmed PY - 2012/9/6/medline SP - 299 EP - 315 JF - Journal of atherosclerosis and thrombosis JO - J Atheroscler Thromb VL - 19 IS - 4 N2 - Patients with chronic kidney disease (CKD) are at an increased risk not only for end-stage kidney disease (ESKD) but also for cardiovascular disease (CVD). In this review article, we summarize the current evidence of CKD as a high-risk condition for CVD based on reports from Japan and other countries to draw attention to the close clinical association between CKD and CVD. Several epidemiologic studies have shown that the presence of CKD and reduced renal function are independent predictors of CVD also in Japan. According to a post-hoc analysis of CASE-J, the power of CKD as a predictor of CVD is as strong as diabetes mellitus and a previous history of ischemic heart disease. CKD worsens classical risk factors including hypertension and dyslipidemia, and dyslipidemia is associated with increased thickness and stiffness of large arteries independent of major confounders. A post-hoc analysis of MEGA indicates that lipid-lowering therapy with statins reduces the risk of CVD, and that it appears to be more efficacious in patients with than without CKD. These reports from Japan and other countries suggest that CKD should be regarded as a high-risk condition comparable to diabetes mellitus, and that strict control of dyslipidemia would be beneficial in preventing CVD, at least early stages of CKD. SN - 1880-3873 UR - https://www.unboundmedicine.com/medline/citation/22166970/Chronic_kidney_disease_dyslipidemia_and_atherosclerosis_ L2 - http://joi.jlc.jst.go.jp/JST.JSTAGE/jat/10454?from=PubMed DB - PRIME DP - Unbound Medicine ER -